The goal of this study is to assess response to kisspeptin as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals with polycystic ovarian syndrome (PCOS).
Reproductive Disorder, PCOS, Polycystic Ovary Syndrome
The goal of this study is to assess response to kisspeptin as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals with polycystic ovarian syndrome (PCOS).
Dampening the Reproductive Axis With Continuous Kisspeptin
-
Massachusetts General Hospital, Boston, Massachusetts, United States, 02114
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 45 Years
FEMALE
No
Stephanie B. Seminara, MD,
Stephanie B Seminara, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital
2025-12-31